Makover
Pharmaceuticals
Kam Biotechnology Ltd
Israel
Biography
Dr. Makover has more than 20 years of experience in various fields of biotech and medical devices including drug development, diagnostics, tissue engineering, as well as venture capital investments. Among her roles, she served as the CEO of a start-up company engaged in proof of concept of tissue banking and tissue culture for tissue engineering. In addition, Dr. Makover serves as a Director at the boards of Evogene (TASE:EVGN), Perfaction Technologies, Earlysense, Genegrafts, Spine21, and as an Observer at Argo Medical. Dr. Makover has earned her joint Ph.D from Columbia University and the Weizmann Institute, and holds an MBA from Bar Ilan University.
Research Interest
tissue culture
